Back to URGN
Point72 Asset Management, L.P. → URGN
Point72 Asset Management, L.P. URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
12
Latest value
$56.1M
Q2 2026
Peak value
$56.1M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $2.9M |
| Q4 2023 | $1.9M |
| Q1 2024 | $16.7M |
| Q2 2024 | $41.1M |
| Q2 2024 | $41.1M |
| Q2 2024 | $41.1M |
| Q3 2024 | $19.1M |
| Q4 2024 | $3.4M |
| Q1 2025 | $2.6M |
| Q1 2025 | $2.6M |
| Q2 2025 | $2.3M |
| Q2 2026 | $56.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $56.1M | 1.53M | — | — |
| Q2 2025 | $2.3M | 168.8K | — | — |
| Q1 2025 | $2.6M | 236.0K | — | — |
| Q1 2025 | $2.6M | 236.0K | — | — |
| Q4 2024 | $3.4M | 317.1K | — | — |
| Q3 2024 | $19.1M | 1.51M | — | — |
| Q2 2024 | $41.1M | 2.45M | — | — |
| Q2 2024 | $41.1M | 2.45M | — | — |
| Q2 2024 | $41.1M | 2.45M | — | — |
| Q1 2024 | $16.7M | 1.11M | — | — |
| Q4 2023 | $1.9M | 126.0K | — | — |
| Q3 2023 | $2.9M | 207.7K | — | — |